Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Secondary Skin Cancer in a Case with Long-term Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Kawano N, Nakamura S, Mochida K, Yoshida S, Kuriyama T, Nakaike T, Shimokawa T, Tochigi T, Yamashita K, Mashiba K, Kikuchi I, Takarabe A, Moriguchi S, Mori Y, Takenaka K, Shimoda K, Ochiai H, Amano M. Kawano N, et al. Intern Med. 2022 Sep 15;61(18):2771-2774. doi: 10.2169/internalmedicine.8618-21. Epub 2022 Jan 13. Intern Med. 2022. PMID: 35022348 Free PMC article.
Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N, Kuriyama T, Yoshida S, Yamashita K, Ochiai H, Nakazaki S, Tasaki A, Ueda A. Kawano N, et al. Intern Med. 2013;52(1):55-62. doi: 10.2169/internalmedicine.52.7978. Epub 2013 Jan 1. Intern Med. 2013. PMID: 23291674 Free article.
Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.
Kawano N, Okuda S, Yoshida S, Kugimiya H, Ito M, Horikawa N, Chosa N, Hisakata T, Fukudome T, Sakurai R, Yamashita K, Ueda A, Kanda Y. Kawano N, et al. Int J Hematol. 2011 Dec;94(6):561-6. doi: 10.1007/s12185-011-0956-y. Epub 2011 Nov 8. Int J Hematol. 2011. PMID: 22057509
Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).
Kawano N, Yoshida S, Kuriyama T, Tahara Y, Yamashita K, Nagahiro Y, Kawano J, Koketsu H, Toyofuku A, Manabe T, Beppu K, Ono N, Himeji D, Yokota-Ikeda N, Inoue S, Ochiai H, Sonoda KH, Shimoda K, Ishikawa F, Ueda A. Kawano N, et al. Among authors: kawano j. Intern Med. 2015;54(12):1489-98. doi: 10.2169/internalmedicine.54.1953. Epub 2015 Jun 15. Intern Med. 2015. PMID: 26073237 Free article.
The Impact of a Humanized CCR4 Antibody (Mogamulizumab) on Patients with Aggressive-Type Adult T-Cell Leukemia-Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation.
Kawano N, Kuriyama T, Yoshida S, Kawano S, Yamano Y, Marutsuka K, Minato S, Yamashita K, Ochiai H, Shimoda K, Ishikawa F, Kikuchi I. Kawano N, et al. Among authors: kawano s. J Clin Exp Hematop. 2017;56(3):135-144. doi: 10.3960/jslrt.56.135. J Clin Exp Hematop. 2017. PMID: 28331127 Free PMC article.
535 results